XML 59 R39.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Investments (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Investments, Debt and Equity Securities [Abstract] |
Schedule of Equity Method Investments | The following table summarizes the Company’s investments in equity securities:
|  | As of December 31,
|  | 2024 |  | 2023
|  | $ |  | $
Equity securities with readily determinable fair values 1 |  |  |  |
Fair value of Leap common stock |  | 2,113 |  |  | 3,046 |
Fair value of Leap warrants |  | 168 |  |  | 542 |
Equity securities without readily determinable fair values |  |  |  |
Pi Health, Inc. 2 |  | 40,798 |  |  | — |
Other |  | 48,157 |  |  | 55,860 |
Equity-method investments |  | 33,081 |  |  | 25,981 |
Total |  | 124,317 |  |  | 85,429 |
1 Represents common stock and warrants to purchase additional shares of common stock of Leap. The Company measures the investment in the common stock and warrants at fair value, with changes in fair value recorded to other (expense) income, net. 2 In the first quarter of 2024, the Company divested the net assets comprising substantially all of its Pi Health business with a carrying value of $38,063. The consideration received for the divestiture consisted of preferred stock in a newly formed entity, Pi Health, Inc., with a fair value of $40,798 and cash consideration of $1,000. The transaction resulted in a pre-tax gain of $3,735 recorded within other (expense) income, net during year ended December 31, 2024. The Company will account for its investment prospectively as a private equity security without a readily determinable fair value and the divestiture is not treated as a discontinued operation in the Statement of Operations and therefore the historical results of operations of the Pi Health business will remain in the Company’s continuing operations. The following table summarizes unrealized (losses) gains related to investments in equity securities recorded in other (expense) income, net:
|  | Year Ended December 31,
|  | 2024 |  | 2023 |  | 2022
|  | $ |  | $ |  | $
Equity securities with readily determinable fair values |  | (1,307) |  |  | (425) |  |  | (30,102) |
Equity securities without readily determinable fair values |  | (7,596) |  |  | (6,448) |  |  | 5,065 |
Equity-method investments |  | (10,275) |  |  | (7,856) |  |  | (3,682) |

X
- Definition Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3 + Details
Name: | us-gaap_EquityMethodInvestmentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration